Shanghai MicroPort MedBot (Group) Co., Ltd. announced that on November 22nd, 2022 MicroPort NaviBot International, LLC in recent collaboration with MicroPort Orthopedics has completed...
Oncolytics Biotech Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to pelareorep in combination with Roche's anti-PD-L1...
Biological Dynamics, a company developing its exosome-isolation ExoVerita platform for early disease diagnostics, announced it has received IRB approval and will soon begin to...
Journey Biosciences, Inc., a biotechnology company offering biomarker-based predictive risk screening technologies for diabetes-related complications, announced the launch of its flagship product NaviDKD.
NaviDKD, a...
